Company Overview and News

3
Keeping equipment quiet

2018-05-31 australianmining.com.au
STAUFF is pleased to present the patented concept of NRC clamps (Noise Reduction Clamps) for reducing noise and vibration in installations of pipes and tubes with outside diameters between 6 and 88.9 mm or ¼ to 3 ½“.
SGLOF SAIGY SAI BVVBY BVINV BVI

3
RFID non-contact technology

2018-05-28 australianmining.com.au
New connection adaptors enable the use of innovative sensors to check hydro-pneumatic accumulators without having to manually work on them.
SGLOF SAIGY SAI BVVBY BVINV BVI

3
Keeping equipment quiet

2018-05-18 australianmining.com.au
STAUFF is pleased to present the NRC-type clamps (Noise Reduction Clamp) for reducing noise and vibration in installations of pipes and tubes with outside diameters between 6 and 88.9 mm or ¼ to 3 ½”.
SGLOF SAIGY SAI BVVBY BVINV BVI

3
RFID non-contact technology: Checking pre-charge pressure on bladder and diaphragm accumulators

2018-05-10 australianmining.com.au
New connection adaptors enable the use of innovative sensors to check hydro-pneumatic accumulators without having to manually work on them.
SGLOF SAIGY SAI BVVBY BVINV BVI

8
CIRCOR Aerospace & Defense California Receives AS9100 Rev D Certification

2018-04-10 globenewswire
CORONA, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- CIRCOR Aerospace Inc., a CIRCOR International company, announced that its Aerospace & Defense California business has been awarded ISO 9001:2015 + AS9100 D certification by its registration partner, SAI Global.
SGLOF SAIGY SAI CIR

3
Snow crab fishery's 'sustainable' label suspended in wake of whale deaths

2018-03-20 cbc.ca
Canada's lucrative snow crab fishery in the southern Gulf of St. Lawrence has had its certification as an environmentally sustainable fishery suspended.
SGLOF SAIGY SAI

3
Snow crab fishery's sustainability designation suspended in wake of whale deaths

2018-03-20 cbc.ca
Canada's lucrative Gulf of St. Lawrence snow crab fishery has had its certification as an environmentally sustainable fishery suspended.
SGLOF SAIGY SAI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:SAI / SAI GLOBAL LIMITED on message board site Silicon Investor.

Saint Jean Carbon Inc Science Applications International Corporation (SAIC)
Saifun Semiconductor (SFUN) USAI: USA Networks, Inc.
MOSAID Technologies Inc. USAI, 61% stake in Ticketmaster Online-CitySearch IPO
HE SAID, SHE SAID Mosaic Group (MGX.TO)
SeaEscape (SEPI). Setting Sail for Profits. RMBS - RAMBUS Eagle -- MDS.T - MOSAID Falcon